More News! For those who want to keep up with everything

More News! 11 Sep 2017

Could a Protein in Yeast hold the Secret to Escaping Age-Related Diseases?

Researchers in Basel, Switzerland have identified a protein in yeast that slows protein synthesis, prolonging their lifespan. Gcn4 is a transcription factor that regulates the expression around 10% of the yeast genome. Nutrient restriction and moderate stress extend lifespan and under these conditions, yeast expresses Gcn4 to regulate protein synthesis. The aim is now to find […]

September 11, 2017 - 2 minutesmins - By Alex Dale

argenx staten biotechnology dyslipidemia

More News! 23 Aug 2017

Dutch Biotech could treat Dyslipidemia with Belgian Nanobody

Argenx’ partner Staten Biotechnology has published results that present a drug licensed from the Belgian biotech as a promising approach to control blood lipid levels. Staten Biotechnology is a young biotech in Breda, the Netherlands, focusing on treating dyslipidemia and reduce cardiovascular mortality and backed by BioGeneration Ventures and Forbion Capital Partners as investors. Back […]

August 23, 2017 - 1 minutemin - By Clara Rodríguez Fernández

Novo Nordisk Semaglutide GLP 1 receptor agonist type 2 diabetes Eli Lilly Trulicity dulaglutide

More News! 18 Aug 2017

Novo Nordisk’s New Type 2 Diabetes Drug Outperforms Eli Lilly’s

Novo Nordisk has reported Phase III data that reveal its candidate semaglutide improved glucose control and weight loss in type 2 diabetes when compared with Eli Lilly’s dulaglutide. The results of the SUSTAIN 7 trial comparing the efficacy of Novo Nordisk’s semaglutide with Eli Lilly’s Trulicity (dulaglutide), already in the market, have revealed that Novo’s […]

August 18, 2017 - 1 minutemin - By Clara Rodríguez Fernández

galapagos glpg1690 idiopathic pulmonary fibrosis

More News! 10 Aug 2017

Belgian Biotech Takes Down Untreatable Lung Disease in Phase II, Eyes the Market

Galapagos’ GLPG1690 wowed analysts with efficacy and tolerability data in idiopathic pulmonary fibrosis treatment, opening the door to the market. Galapagos, based in Mechelen, Belgium, has reported a win in Phase IIa for its candidate GLPG1690, which aims to treat patients with idiopathic pulmonary fibrosis (IPF). The median survival is 2 to 5 years after […]

August 10, 2017 - 2 minutesmins - By Evelyn Warner

More News! 9 Aug 2017

UK Cannabinoid Company Loses 9% and a Competitor after American Phase II Failure

Zynerba Pharmaceuticals cannabinoid drug for epilepsy missed all of its endpoints costing the company’s stock price more than 55% — and GW Pharma 8.6%. On Monday, Zynerba Pharmaceuticals, a Pennsylvania-based biotech, announced that its transdermal cannabinoid candidate ZYN002 for refractory epilepsy with focal seizures had not met any of its endpoints in a Phase II […]

August 9, 2017 - 2 minutesmins - By Evelyn Warner

More News! 24 Jul 2017

Bayer and Evotec Extend their Endometriosis Partnership

Bayer and Evotec have decided to extend their partnership for the development of endometriosis drugs now that their second candidate has made it to Phase I. Bayer and Evotec have announced today that a second compound derived from their endometriosis partnership has made it to clinical trials. The team has decided to extend the partnership […]

July 24, 2017 - 1 minutemin - By Clara Rodríguez Fernández

More News! 17 Jul 2017

Israeli Biotech Partners with German Chem Giant to Develop Non-GMO Herbicide Resistance

Kaiima and BASF have partnered to develop crops with new herbicide resistance traits using non-GMO genetic engineering technology. Kaiima Bio Agritech works on boosting crop performance by using the plant’s own DNA, without the need of introducing external genes. In order to leverage this technology, the company has partnered with the giant chemical company BASF to discover […]

July 17, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 15 Jul 2017

Speculative Biology in Art: How will Life Look like in the Future?

The first solo exhibition of Turkish artist Pinar Yoldas imagines a future where biology is shaped by climate change and plastic pollution. Last week in Amsterdam opened Carboniferous, a solo bioart exhibition by Pinar Yoldas focusing on speculative biology. This concept revolves around imagining how life will evolve according to predictions of how the planet’s future ecosystems […]

July 15, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

liver transplant cambridge university research

More News! 6 Jul 2017

Lab-Grown Bile Ducts Can Replace Liver Transplant in Mice

A new study describes a method that could be used to regenerate bile ducts in children with biliary atresia instead of waiting for a liver transplant. Researchers at the University of Cambridge might have found an alternative to transplant for children with liver disease. Their results, published today in Nature Medicine, reveal that primitive bile ducts grown […]

July 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 30 Jun 2017

Fig Enzyme could Help to fight Infection and Heal Wounds

Russian researchers have investigated the properties of ficin, an enzyme that breaks down proteins, in helping antibiotics be more effective against infections like Staphylococcus. At Kazan Federal University and Voronezh University, in Russia, researchers are turning their attention to an understudied protease extracted from fig’s latex. As now published in Scientific Reports, the enzyme turned out to […]

June 30, 2017 - 2 minutesmins - By Denise Neves Gameiro

More News! 27 Jun 2017

Green Biotech Enters Partnership to Advance the Infinite Recycling of Plastics

Carbios has teamed up with TechnipFMC in order to move Carbios’ enzymatic recycling process for PET plastics from the laboratory to the pilot scale. French Carbios is looking to combat the limits of current thermo-mechanical recycling processes using an enzyme-based degradation process that paves the way to infinite recycling of PET. The annual production of PET, one […]

June 27, 2017 - 2 minutesmins - By Melanie De Almeida

More News! 23 Jun 2017

French Biotech Raises Over €22M to Launch a Gene Therapy to Restore Sight

Gensight Biologics has announced a capital increase that totals €22.5M and will support the launch of its gene therapy for blindness in Europe and the US. Gensight has decided to give an additional financial push to its lead candidate, GS010, a gene therapy to restore sight in patients with the rare genetic disease Leber hereditary optic […]

June 23, 2017 - 1 minutemin - By Clara Rodríguez Fernández

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

More News!

Could a Protein in Yeast hold the Secret to Escaping Age-Related Diseases?

Dutch Biotech could treat Dyslipidemia with Belgian Nanobody

Novo Nordisk’s New Type 2 Diabetes Drug Outperforms Eli Lilly’s

Belgian Biotech Takes Down Untreatable Lung Disease in Phase II, Eyes the Market

UK Cannabinoid Company Loses 9% and a Competitor after American Phase II Failure

Bayer and Evotec Extend their Endometriosis Partnership

Israeli Biotech Partners with German Chem Giant to Develop Non-GMO Herbicide Resistance

Speculative Biology in Art: How will Life Look like in the Future?

Lab-Grown Bile Ducts Can Replace Liver Transplant in Mice

Fig Enzyme could Help to fight Infection and Heal Wounds

Green Biotech Enters Partnership to Advance the Infinite Recycling of Plastics

French Biotech Raises Over €22M to Launch a Gene Therapy to Restore Sight

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!